Online Only Articles

The clinical impact of ponatinib on the risk of bleeding in patients with chronic myeloid leukemia

The Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA
The Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA
The Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA
The Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA
Vol. 98 No. 10 (2013): October, 2013 https://doi.org/10.3324/haematol.2013.091678